Capstone Holding (CAPS) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual meeting scheduled for November 18, 2025, to be held virtually for shareholder participation.
Proxy materials, including the 2024 Annual Report, are available online for review and voting.
Shareholders are encouraged to vote electronically or request paper copies of materials by November 3, 2025.
Voting matters and shareholder proposals
Election of two Class I directors: Elwood D. Howse, Jr. and Fredric J. Feldman, Ph.D.
Ratification of GBQ Partners LLC as independent auditor for fiscal year ending December 31, 2025.
Approval of a change in state of incorporation from Delaware to Nevada via merger with a Nevada subsidiary.
Approval of the 2025 Stock Incentive Plan.
Advisory vote on executive compensation and frequency of future say-on-pay votes (Board recommends three years).
Approval of possible future payments to Nectarine Management LLC.
Authorization to transact other business as may properly come before the meeting.
Board of directors and corporate governance
Board recommends voting FOR all proposals except Proposal 6, where it recommends a three-year frequency for say-on-pay votes.
Latest events from Capstone Holding
- Annual meeting covers director elections, re-domicile, equity plan, and related party approvals.CAPS
Proxy Filing2 Dec 2025 - Key votes include director elections, Nevada re-domicile, and a major new stock incentive plan.CAPS
Proxy Filing2 Dec 2025 - Offering 1.25M shares at $4.00 to fund growth, repay debt, and expand in a fragmented market.CAPS
Registration Filing29 Nov 2025 - IPO seeks $3.56M to fund growth and repay debt, with significant dilution and industry headwinds.CAPS
Registration Filing29 Nov 2025 - Equity line enables up to $20M in funding for M&A-driven growth, with dilution risk.CAPS
Registration Filing29 Nov 2025 - IPO aims to fund growth and repay debt, but new investors face dilution and industry risks.CAPS
Registration Filing29 Nov 2025 - Offering up to 4.1M shares via note conversion, supporting M&A-driven growth but causing dilution.CAPS
Registration Filing29 Nov 2025 - Equity line offering of up to 5.19M shares targets $20M for growth, with dilution risk.CAPS
Registration Filing29 Nov 2025 - Q3 revenue and EBITDA rose sharply, with acquisitions fueling growth toward a $100M run-rate.CAPS
Q3 202518 Nov 2025